Skip to main navigation Skip to search Skip to main content

Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion

  • E. C. Rackow
  • , C. Mecher
  • , M. E. Astiz
  • , M. Griffel
  • , J. L. Falk
  • , M. H. Weil
  • Rosalind Franklin University of Medicine and Science

Research output: Contribution to journalArticlepeer-review

104 Scopus citations

Abstract

Twenty consecutive patients with severe sepsis were randomized to fluid challenge with 5% albumin or 10% low MW hydroxyethyl starch (pentastarch) solutions. Fluid challenge was administered iv as 250 ml of test colloid every 15 min until the pulmonary artery wedge pressure (WP) was ≥15 mm Hg or a maximum dose of 2000 ml was infused. Hemodynamic, respiratory, and coagulation profiles were measured before and after fluid infusion. The amount of colloid required to achieve a WP of 15 mm Hg was comparable between groups. Both colloid infusions resulted in similar increases in cardiac output, stroke output, and stroke work. The effect of fluid infusion with pentastarch on coagulation was not significantly different from albumin, although pentastarch was associated with a 45% decrease in factor VIII:c. We conclude that pentastarch is equivalent to albumin for fluid resuscitation of patients with severe sepsis.

Original languageEnglish
Pages (from-to)394-398
Number of pages5
JournalCritical Care Medicine
Volume17
Issue number5
DOIs
StatePublished - 1989

Fingerprint

Dive into the research topics of 'Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion'. Together they form a unique fingerprint.

Cite this